echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The latest paper in "Nature" reveals why the new crown vaccine booster is still effective for Omicron

    The latest paper in "Nature" reveals why the new crown vaccine booster is still effective for Omicron

    • Last Update: 2022-05-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    China News Service, Beijing, April 22 (Reporter Sun Zifa) The world-renowned academic journal "Nature" recently published an immunological study on "Why the new crown vaccine developed for the original strain is still effective against Omicron" The paper shows that the third dose of the mRNA vaccine developed for the original new coronavirus (SARS-CoV-2) can enhance the ability of the immune system to produce broad-spectrum neutralizing antibodies, including the ability to neutralize Omi, compared with only two doses.


    The research findings help explain why mRNA vaccines based on the original new coronavirus strain, as boosters, are still effective against newly created variants, the paper said


    The co-corresponding author of the paper, Michel Nussenzweig of the Rockefeller University in the United States, and his colleagues and scientific colleagues cooperated with 42 people who had received three mRNA vaccines (8 vaccinated with Modena, 34 vaccinated with Pfizer- BioNTech) blood samples were analyzed, which were collected after the first, second and third doses, while none of the study participants had been infected with the new coronavirus


    They observed that the blood samples after the third injection had an increased range of memory B cells compared to the blood samples after the second injection, and memory B cells can quickly respond to the new coronavirus and produce antibodies


    The authors noted that the increased potency of the antibody after the third dose is because the antibodies produced by the emerging memory B cells can target more of the receptor-binding domain (the part of the virus that facilitates entry into host cells)



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.